Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Alexis

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
International Journal of Dermatology|April 29, 2024
Importance of treating acne sequelae in skin of color: 6-month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne-induced post-inflammatory hyperpigmentationAndrew Alexis, James Q Del Rosso, Seth Forman, et al.
American Journal of Clinical Dermatology|July 15, 2025
Efficacy and Safety of Lebrikizumab in Adult and Adolescent Patients with Skin of Color and Moderate-to-Severe Atopic Dermatitis: Results from the Phase IIIb, Open-Label ADmirable StudyAndrew Alexis, Ali Moiin, Jill Waibel, et al.
Dermatology and Therapy|February 21, 2025
Recommendations to Improve Outcomes in Acne and Acne Sequelae: A Focus on Trifarotene and Other RetinoidsNaiem Issa, Andrew Alexis, Hilary Baldwin, et al.
The Journal of Investigative Dermatology|November 7, 2025
Pigmentary Disorders around the World: Self-Reported Prevalence and Impact on QOL and Social StigmatizationThierry Passeron, Wei Liu, Akimichi Morita, et al.
Dermatology and Therapy|March 2, 2026
The Impact of Post-inflammatory Pigment Alteration After Psoriasis: Novel Data from the VISIBLE StudyAndrew Alexis, Amy McMichael, Neelam Vashi, et al.
JAAD International|June 5, 2023
The Personalized Acne Treatment Tool - Recommendations to facilitate a patient-centered approach to acne management from the Personalizing Acne: Consensus of ExpertsAlison M Layton, Andrew Alexis, Hilary Baldwin, et al.
Dermatology and Therapy|April 26, 2019
Skin Bleaching Among African and Afro-Caribbean Women in New York City: Primary Findings from a P30 Pilot StudyEmma K T Benn, Richa Deshpande, Ogonnaya Dotson-Newman, et al.
The Journal of Clinical and Aesthetic Dermatology|December 28, 2018
BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne VulgarisAndrew Alexis, James Q Del Rosso, Seemal R Desai, et al.
JAMA Dermatology|December 11, 2024
Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality ImprovementAndrew Alexis, Amy McMichael, Neelam Vashi, et al.
Clinical and Experimental Dermatology|August 12, 2025
Stigmatization in patients with pigmentation disorders: the ISPOT studyThierry Passeron, Wei Liu, Akimichi Morita, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
International Journal of Dermatology|April 29, 2024
Importance of treating acne sequelae in skin of color: 6-month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne-induced post-inflammatory hyperpigmentationAndrew Alexis, James Q Del Rosso, Seth Forman, et al.
American Journal of Clinical Dermatology|July 15, 2025
Efficacy and Safety of Lebrikizumab in Adult and Adolescent Patients with Skin of Color and Moderate-to-Severe Atopic Dermatitis: Results from the Phase IIIb, Open-Label ADmirable StudyAndrew Alexis, Ali Moiin, Jill Waibel, et al.
Dermatology and Therapy|February 21, 2025
Recommendations to Improve Outcomes in Acne and Acne Sequelae: A Focus on Trifarotene and Other RetinoidsNaiem Issa, Andrew Alexis, Hilary Baldwin, et al.
The Journal of Investigative Dermatology|November 7, 2025
Pigmentary Disorders around the World: Self-Reported Prevalence and Impact on QOL and Social StigmatizationThierry Passeron, Wei Liu, Akimichi Morita, et al.
Dermatology and Therapy|March 2, 2026
The Impact of Post-inflammatory Pigment Alteration After Psoriasis: Novel Data from the VISIBLE StudyAndrew Alexis, Amy McMichael, Neelam Vashi, et al.
JAAD International|June 5, 2023
The Personalized Acne Treatment Tool - Recommendations to facilitate a patient-centered approach to acne management from the Personalizing Acne: Consensus of ExpertsAlison M Layton, Andrew Alexis, Hilary Baldwin, et al.
Dermatology and Therapy|April 26, 2019
Skin Bleaching Among African and Afro-Caribbean Women in New York City: Primary Findings from a P30 Pilot StudyEmma K T Benn, Richa Deshpande, Ogonnaya Dotson-Newman, et al.
The Journal of Clinical and Aesthetic Dermatology|December 28, 2018
BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne VulgarisAndrew Alexis, James Q Del Rosso, Seemal R Desai, et al.
JAMA Dermatology|December 11, 2024
Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality ImprovementAndrew Alexis, Amy McMichael, Neelam Vashi, et al.
Clinical and Experimental Dermatology|August 12, 2025
Stigmatization in patients with pigmentation disorders: the ISPOT studyThierry Passeron, Wei Liu, Akimichi Morita, et al.
Pageof 8